Telix Pharmaceuticals (TLPPF) Goodwill & Intangibles (2023 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Goodwill & Intangibles for 4 consecutive years, with $584.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles changed N/A year-over-year to $584.6 million in Q2 2026; TTM through Jun 2026 was $584.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $592.8 million, up 129.9% from the prior year.
• Goodwill & Intangibles was $584.6 million for Q2 2026 at Telix Pharmaceuticals, down from $592.8 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $592.8 million in Q4 2025 and troughed at $71.4 million in Q4 2023.
• A 4-year average of $380.2 million and a median of $428.4 million in 2024 frame the typical range for Goodwill & Intangibles.
• Across the five-year window, Goodwill & Intangibles jumped 281.2% in 2024 and jumped 117.84% in 2025, its largest moves.
• Over 4 years, Goodwill & Intangibles stood at $71.4 million in 2023, then jumped by 281.2% to $272.1 million in 2024, then jumped by 117.84% to $592.8 million in 2025, then declined by 1.39% to $584.6 million in 2026.
• The last three Goodwill & Intangibles figures came in at $584.6 million (Q2 2026), $592.8 million (Q4 2025), and $272.1 million (Q4 2024), per Business Quant data.